| Document |
Document Title |
|
WO/2024/143206A1 |
A method for producing phthalonitrile including: a generation reaction step for reacting ammonia, oxygen, and xylene in the presence of a catalyst and obtaining a reaction product gas containing at least a phthalonitrile and urea; a coll...
|
|
WO/2024/140595A1 |
Disclosed in the present invention are a tricyclic compound, a pharmaceutical composition thereof and the use thereof. Specifically, disclosed in the present invention is a compound as represented by formula (I) or a pharmaceutically acc...
|
|
WO/2024/134973A1 |
The present invention addresses the problem of providing: a compound which enables the achievement of a liquid crystal composition that has a large Δn value, a large Δεr value, and good storage properties at room temperature or low te...
|
|
WO/2024/130897A1 |
The present invention relates to the field of fine chemicals. Disclosed is a preparation method for crotononitrile. Cheap and easily available crotonic acid is used as a starting raw material to prepare single-configuration trans-crotono...
|
|
WO/2024/135525A1 |
Provided is a catalyst comprising a metallic oxide which contains molybdenum and vanadium, said catalyst further comprising a P1 crystal and a P2 crystal, where the ratio of the crystal lattice constant of the P2 crystal in the C-axis di...
|
|
WO/2024/121084A1 |
The present invention describes a process for the preparation of aromatic or heteroaromatic nitriles.
|
|
WO/2024/122629A1 |
The present invention addresses the problem of providing: a dye for dying fibers using supercritical carbon dioxide, which can dye fibers highly dense yellow and can provide a dyed product having excellent color fastness to light, sublim...
|
|
WO/2024/122345A1 |
The present invention addresses the problem of providing a method for producing a homo-coupling reaction product, whereby it becomes possible to substantially eliminate the use of an organic solvent, to carry out a reaction under a mild ...
|
|
WO/2024/120808A1 |
The present invention relates to a mixture of two specific cyclohexane carbonitrile isomers and a production method thereof. Furthermore, the invention refers to the use of said isomeric mixture as polar solvent in a hydrogen peroxide pr...
|
|
WO/2024/122652A1 |
Provided are a photoelectric conversion element having excellent response speed and high external quantum efficiency, an imaging element, and a photoelectric conversion element material that contributes to producing said elements. A phot...
|
|
WO/2024/122569A1 |
This fluorine-containing ether compound is represented by a formula. R1-CH2-R2-(CH2-OCH2-CR3R4-CH2O-CH2-R2)z-CH2-R5 (where z is 1 or 2; R2 is a perfluoropolyether chain; R1 and R5 are each a C1-50 terminal group having at least one polar...
|
|
WO/2024/116197A1 |
The present invention relates to an improved process for the preparation of 2- Amino-5-cyano-3, N-dimethylbenzamide of Formula-I, which is an advanced intermediate of Cyantraniliprole.
|
|
WO/2024/116994A1 |
The present invention relates to an acrylonitrile composition containing at least one compound selected from among nitrile compounds represented by general formula (I) and nitrile compounds represented by general formula (II) in an amoun...
|
|
WO/2024/110227A1 |
The present invention relates to a process for the preparation of 4-cyanobenzoyl chlorides of formula (I) from alkali metal 4-carbamoyl-benzoate of formula (II) with a chlorinating agent and a catalyst.
|
|
WO/2024/110260A1 |
The present invention relates to a novel synthesis for a cyclohexane carbonitrile solvent, in particular for 1-cyano-1,3,3-trimethyl-cyclohexane, and its use as polar solvent in a hydrogen peroxide production process using alkylanthraqui...
|
|
WO/2024/105421A1 |
α,β-Unsaturated aldehydes are useful products as such in agrochemistry, but also potential intermediates for the preparation of important insect pheromones and kairomones. Until now, primarily the thermodynamically more stable (E)-α,Î...
|
|
WO/2024/104450A1 |
Disclosed in the present invention is a method for preparing heptafluoroisobutyronitrile by gas-phase catalysis. The method comprises: under the action of a catalyst, removing one water molecule from heptafluoroisobutyramide gas to obtai...
|
|
WO/2024/100221A1 |
The present invention relates to a novel synthesis for cyclohexane carbonitrile solvents and their use as polar solvents in a hydrogen peroxide production process using alkylanthraquinones and/or their tetrahydro form.
|
|
WO/2024/097927A1 |
A process for regenerating a deactivated catalyst for preparing 6-aminocapronitrile, the process comprising contacting a deactivated aluminosilicate zeolite catalyst comprising a nitrogen-containing contaminant with an oxidant to provide...
|
|
WO/2024/097931A1 |
A process for converting caprolactam to aminocapronitrile (ACN), the process comprising contacting a caprolactam feed stream with ammonia to produce a first crude product stream; separating the first crude product stream to produce an in...
|
|
WO/2024/090544A1 |
The purpose of the present invention is to provide a methacrylate–containing composition that has high quality stability during storage.　The methacrylate-containing composition according to one example contains methacrylate, a compou...
|
|
WO/2024/087613A1 |
Provided in the present invention are a preparation method for an intermediate compound used for preparing a heptafluoroisopropyl-containing bisamide compound, and a preparation method for the heptafluoroisopropyl-containing bisamide com...
|
|
WO/2024/089421A1 |
The invention relates to compounds of formula (I) and related aspects.
|
|
WO/2024/081857A1 |
A process for converting caprolactam to aminocapronitrile, the process comprising contacting a caprolactam feed with ammonia and an aluminosilicate zeolite catalyst to produce an aminocapronitrile product, wherein the catalyst comprises ...
|
|
WO/2024/074779A1 |
The present invention relates to a method for granulating an azo compound, comprising the following steps: a) a step of granulating by agitating an aqueous suspension of said azo compound, in the presence of an organic binder; b) an opti...
|
|
WO/2024/071392A1 |
This fluorine-containing ether compound is represented by the following formula. R1-CH2-R2(-CH2-R3-CH2-R2)x-CH2-R4 (In the formula, x represents an integer of 1 or 2; R2 represents a perfluoropolyether chain; R3 is represented by formula...
|
|
WO/2024/073383A1 |
Disclosed herein are substituted compounds of formula (I), salts, and pharmaceutical formulations thereof, for the treatment of a central nervous system disease or disorder.
|
|
WO/2024/071399A1 |
This fluorine-containing ether compound is represented by the following formula. R1-CH2-R2[-CH2-R3-CH2-R2]x-CH2-R4 (x is 1 or 2. R2 is a perfluoropolyether chain. R3 is represented by formula (2). R1 and R4 are terminal groups having 1-5...
|
|
WO/2024/061348A1 |
The present invention provides a 1,3-cyclohexanedione compound shown in formula I, and a stereoisomer and an agrochemically acceptable salt thereof, wherein R1, R2, R3, and R4 are as defined in the description. Also disclosed are a prepa...
|
|
WO/2024/061523A1 |
The present invention relates to an electroluminescent device comprising a radialene of formula (I) and an arylamine compound, diarylamine compound, triarylamine compound or a compound of formula (II), and a display device comprising the...
|
|
WO/2024/056678A1 |
The present invention relates to compounds according to formula (I), which are prodrugs of the psychoactive compound phenethylamine or its derivatives. The prodrugs provided herein exhibit improved pharmacokinetic properties during uptak...
|
|
WO/2024/046605A1 |
The compounds of formula (IA) or formula (IB) or a salt thereof. The compounds can be used as reference products in the determination of the administration of ligandrol to a subject.
|
|
WO/2024/045034A1 |
Disclosed in the present invention is a method for dehydrogenation esterification of an aryl phenol and an aromatic aldehyde by means of a light/nickel dual-catalysis system in the absence of an oxidant and an external photosensitizer. S...
|
|
WO/2024/038436A1 |
The present invention relates to the preparation of cyantraniliprole, comprising the preparation of 8-methyl-2,4-dioxo-l,4-dihydro-2H-benzo[d][l,3]oxazine-6-car
bonitrile key intermediate via 2-amino-5-((hydroxyimino)methyl)-3-methylbenz...
|
|
WO/2024/029481A1 |
Provided is an anti-HBV agent comprising a compound represented by formula (I) or a salt thereof. [In the formula, R1 is a phenyl group substituted with a group represented by -CN or R3-NH-CO- and an alkyl group having 1-6 carbon atoms, ...
|
|
WO/2024/028717A1 |
A ligand which contains arsenic and has the formula (I): where n is 2 and the ligand is bidentate; each X is O or NH; and Ar1 and Ar2 may be the same or different and each is an aryl group, provided that each Ar1 group connected to the s...
|
|
WO/2024/030736A1 |
Processes and facilities for producing several types of recycled content organic chemical compounds from waste plastic. Processing schemes are described herein for converting waste plastic (or hydrocarbon having recycled content derived ...
|
|
WO/2024/028716A1 |
A process for the hydrocyanation of an organic compound containing at least one olefinic group comprising reacting the organic compound with hydrogen cyanide in the presence of a catalyst complex comprising at least one transition metal ...
|
|
WO/2024/030674A1 |
Disclosed herein is a microcavity comprising a photoluminescent material positioned between two reflectors, wherein the photoluminescent material comprises a cationic molecular dye, a macrocyclic anion receptor host, and an anion embedde...
|
|
WO/2024/028715A1 |
A process for the hydrocyanation of an organic compound containing at least one olefinic group comprising reacting the organic compound with hydrogen cyanide in the presence of a catalyst complex comprising at least one transition metal ...
|
|
WO/2024/024973A1 |
A method for producing a catalyst that is used in a vapor-phase contact ammoxidation reaction, wherein: the catalyst is such that a metal oxide containing at least Mo and Sb is carried on a silica support; the method includes a sintering...
|
|
WO/2024/024781A1 |
This fluorine-containing ether compound is represented by the following formula. R1-CH2-R2[-CH2-R3-CH2-R2]x-CH2-R4 (x represents an integer of 1 or 2, R2 represents a perfluoropolyether chain, at least one of the x-number of R3 is repres...
|
|
WO/2024/024766A1 |
The purpose of the present invention is to provide an alkylating agent that can alkylate a hydroxyl group at 2' position of a synthetic intermediate for an amidite compound in the presence of a base. The present invention provides an alk...
|
|
WO/2024/022491A1 |
Provided are a compound of Formula (I) as an FTO inhibitor with improved and selective FTO inhibition, a pharmaceutical composition comprising the same, and a method of inhibiting weight gain, promoting weight loss, reducing serum LDL, c...
|
|
WO/2024/014325A1 |
An aromatic compound configured from a stable isotope, wherein two adjacent carbon atoms are 13C, the nuclear spin quantum number of the other atoms to which the two adjacent carbon atoms bond is 0, and a hydrogen atom that has a spin co...
|
|
WO/2024/005520A1 |
The present invention relates to intestine-specific partial agonists of farnesoid X receptor (FXR), methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compou...
|
|
WO/2024/000734A1 |
A mesoporous nickel powder and a preparation method therefor, and a nickel-phosphorus catalyst system. The mesoporous nickel powder comprises powder-like particles of metallic nickel, the average particle size of the particles being 1-10...
|
|
WO/2023/247598A1 |
The present invention relates to a compound represented by the following formula (I): [(A)n-B1]m(X)x[B2-(C)n']m' (I), wherein X is a radical derived from an aryl, a heteroaryl, a polyol, a saccharide, an amino-acid, a peptide, or a polya...
|
|
WO/2023/243522A1 |
The purpose of the present invention is to provide a method for producing an aromatic compound, wherein a cross-coupling reaction by means of a mechanochemical process is carried out in a state where a solvent is not substantially contai...
|
|
WO/2023/242106A1 |
The present invention relates to the use of compounds of formula (I) as RAS inhibitors and as a medicament, in particular for use in treating proliferative disorders inflammatory diseases and/or genetic disorders. The present invention r...
|
